Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhieddine Labban

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
European Urology Focus|October 14, 2022
Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial NephrectomyWei Shen Tan, Mara Koelker, Nicholas Campain, et al.
European Urology|September 27, 2023
Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data BaseEdoardo Beatrici, Muhieddine Labban, Benjamin V Stone, et al.
Urology Practice|September 6, 2024
SGLT2 Inhibitor and Urinary Tract Infection in Men at Risk for Voiding Dysfunction: A VigiBase AnalysisZhiyu Qian, Jonathan Song, Alyssa Jones, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United StatesThomas Seisen, Muhieddine Labban, Stuart R Lipsitz, et al.
JNCI Cancer Spectrum|December 19, 2024
Socioeconomic determinants of cancer screening adherence among cancer survivors: analysis from the 2020 Behavioral Risk Factor Surveillance SystemEdoardo Beatrici, Zhiyu Qian, Dejan K Filipas, et al.
Urology|August 29, 2024
Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare SystemZhiyu Qian, Yu-Jen Chen, Precious Moman, et al.
Cancer|June 5, 2024
A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in MassachusettsMuhieddine Labban, Benjamin V Stone, Grant L Steele, et al.
Urology Practice|July 27, 2023
Predictors of Financial Toxicity Among United States Prostate Cancer Survivors: Results From a National SurveyBenjamin V Stone, Muhieddine Labban, Dejan K Filipas, et al.
Urology|August 20, 2023
Association of Urinary Incontinence and Depression: Findings From the National Health and Nutrition Examination SurveyDejan K Filipas, Muhieddine Labban, Edoardo Beatrici, et al.
The Canadian Journal of Urology|June 21, 2023
Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database reviewDavid-Dan Nguyen, Massine Fellouah, Anna-Lisa V Nguyen, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
European Urology Focus|October 14, 2022
Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial NephrectomyWei Shen Tan, Mara Koelker, Nicholas Campain, et al.
European Urology|September 27, 2023
Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data BaseEdoardo Beatrici, Muhieddine Labban, Benjamin V Stone, et al.
Urology Practice|September 6, 2024
SGLT2 Inhibitor and Urinary Tract Infection in Men at Risk for Voiding Dysfunction: A VigiBase AnalysisZhiyu Qian, Jonathan Song, Alyssa Jones, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United StatesThomas Seisen, Muhieddine Labban, Stuart R Lipsitz, et al.
JNCI Cancer Spectrum|December 19, 2024
Socioeconomic determinants of cancer screening adherence among cancer survivors: analysis from the 2020 Behavioral Risk Factor Surveillance SystemEdoardo Beatrici, Zhiyu Qian, Dejan K Filipas, et al.
Urology|August 29, 2024
Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare SystemZhiyu Qian, Yu-Jen Chen, Precious Moman, et al.
Cancer|June 5, 2024
A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in MassachusettsMuhieddine Labban, Benjamin V Stone, Grant L Steele, et al.
Urology Practice|July 27, 2023
Predictors of Financial Toxicity Among United States Prostate Cancer Survivors: Results From a National SurveyBenjamin V Stone, Muhieddine Labban, Dejan K Filipas, et al.
Urology|August 20, 2023
Association of Urinary Incontinence and Depression: Findings From the National Health and Nutrition Examination SurveyDejan K Filipas, Muhieddine Labban, Edoardo Beatrici, et al.
The Canadian Journal of Urology|June 21, 2023
Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database reviewDavid-Dan Nguyen, Massine Fellouah, Anna-Lisa V Nguyen, et al.
Pageof 8